找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Alzheimer Disease; Therapeutic Strategi Ezio Giacobini (Chairman of Pharmacology),Robert E Conference proceedings 1994 Springer Science+Bus

[复制链接]
楼主: Racket
发表于 2025-3-26 23:48:26 | 显示全部楼层
Alzheimer Disease -- A Spirochetosis?e of neuroborreliosis caused by . (Burgdorfer et al., 1982; Pachner et al., 1989), and general paresis, tertiary stage of neurosyphilis caused by .. Two cases of concurrent neocortical borreliosis and Alzheimer disease (AD) have been reported (MacDonald and Miranda, 1987; MacDonald, 1988): immunosta
发表于 2025-3-27 03:17:52 | 显示全部楼层
发表于 2025-3-27 07:31:21 | 显示全部楼层
发表于 2025-3-27 11:17:35 | 显示全部楼层
发表于 2025-3-27 16:37:59 | 显示全部楼层
Apolipoprotein E and Alzheimer’s Disease: Therapeutic Implicationsd with late-onset familial (Strittmatter et al., 1993a) and sporadic (Saunders et al., 1993) AD. Three major protein isoforms of apoE (apoE2, E3 and E4) are the products of three alleles є2, є3, є4 at a single gene locus on the proximal long arm of chromosome 19q13.2 (Mahley, 1988), within the regio
发表于 2025-3-27 17:46:36 | 显示全部楼层
Apolipoprotein E4 and Cholinergic Dysfunction in Alzheimer’s Diseaseily by the liver, but also at other sites including brain, macrophages and adrenals (Elshourbagy et al., 1985). Furthermore, apoE is unique among apolipoproteins in that it has a special relevance to the central and peripheral nervous systems. It is a key determinant in the cellular recognition and
发表于 2025-3-27 22:11:35 | 显示全部楼层
发表于 2025-3-28 05:27:16 | 显示全部楼层
Modulating Cholinergic Neurotransmission Through Transgenic Overexpression of Human Cholinesterasestem (Harding, 1992), suggesting that experimental modulation of cholinergic neurotransmission can serve to study the relationship between cholinergic deficits and neuropathology. To this end, we established transgenic models for overexpressing human cholinesterases (ChEs) (Soreq and Zakut, 1993) in
发表于 2025-3-28 07:00:14 | 显示全部楼层
Structure-Function Relationships in The Binding of Reversible Inhibitors in the Active-Site Gorge ofase agents are used in treatment of various disorders (Taylor, 1990), and have been proposed as therapeutic agents for managing Alzheimer’s disease (AD) (Becker and Giacobini, 1991). The AChE active site contains a catalytic subsite and a so-called `anionic’ subsite, which binds the quaternary group
发表于 2025-3-28 14:23:13 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-27 12:21
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表